HeartSciences Inc.
HSCSDrugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Standard medical therapy | Phase 3 | Heart Failure | - | - |
Frequently asked questions
What is in HeartSciences Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in HeartSciences Inc.'s (HSCS) pipeline across Phase 3. Its lead program is Standard medical therapy (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is HeartSciences Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for HeartSciences Inc. (HSCS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track HSCS biotech catalysts?→
Add HSCS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow HeartSciences Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.